Horizon Therapeutics
In Howard Marks's portfolio · Oaktree Capital Management
Ticker HZNP.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2018 | Reduce 11% | 41,281,000 | 0.6% |
| Q2 2018 | Add 23% | 46,262,000 | 0.6% |
| Q1 2018 | Add 43% | 37,487,000 | 0.5% |
| Q1 2017 | Sell | 0 | |
| Q4 2016 | Reduce 13% | 42,060,000 | 0.6% |
| Q3 2016 | Add 18% | 48,360,000 | 0.6% |
| Q2 2016 | Add 62% | 40,989,000 | 0.7% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.